Inventor
BEBBINGTON CHRISTOPHER ROBERT
US21 patents
⚠️ This page may combine multiple inventors who share the name “BEBBINGTON CHRISTOPHER ROBERT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
OXFORD BIOMEDICA LTD
6 patentsUS7303910B2Dec 4, 2007
Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site
OXFORD BIOMEDICA LTD137 citations97
US6852703B1Feb 8, 2005
Tumor targeted vector
OXFORD BIOMEDICA LTD39 citations94
US7074909B2Jul 11, 2006
Antibodies
OXFORD BIOMEDICA LTD27 citations89
US7531648B2May 12, 2009
Vector encoding an antibody that binds 5T4 antigen
OXFORD BIOMEDICA LTD8 citations82
US6808922B1Oct 26, 2004
Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site
OXFORD BIOMEDICA LTD14 citations82
US7635687B2Dec 22, 2009
Vector system
OXFORD BIOMEDICA LTD2 citations59
ALUSUISSE HOLDINGS AG
4 patentsUS5879936AMar 9, 1999
Recombinant DNA methods, vectors and host cells
ALUSUISSE HOLDINGS AG65 citations95
US5891693AApr 6, 1999
Recombinant DNA methods vectors and host cells
ALUSUISSE HOLDINGS AG77 citations94
US5747308AMay 5, 1998
Recombinant DNA method
ALUSUISSE HOLDINGS AG27 citations91
US5866359AFeb 2, 1999
Transactivation method of regulating foreign gene expression
ALUSUISSE HOLDINGS AG9 citations71
ALLAKOS INC
4 patentsUS10604577B2Mar 31, 2020
Methods and compositions for treating systemic mastocytosis
ALLAKOS INC5 citations70
US10183996B2Jan 22, 2019
Methods and compositions for treating Siglec-8 associated diseases
ALLAKOS INC6 citations70
US11203638B2Dec 21, 2021
Methods and compositions for treating perennial allergic conjunctivitis and keratoconjunctivitis
ALLAKOS INC2 citations68
US10774145B2Sep 15, 2020
Methods and compositions for treating fibrotic diseases
ALLAKOS INC3 citations68